179 related articles for article (PubMed ID: 33023064)
1. Vitamin D as a Primer for Oncolytic Viral Therapy in Colon Cancer Models.
Kim SI; Chaurasiya S; Park AK; Kang S; Lu J; Woo Y; Yin HH; Yin Z; Fong Y; Warner SG
Int J Mol Sci; 2020 Oct; 21(19):. PubMed ID: 33023064
[TBL] [Abstract][Full Text] [Related]
2. A cancer-favoring oncolytic vaccinia virus shows enhanced suppression of stem-cell like colon cancer.
Yoo SY; Bang SY; Jeong SN; Kang DH; Heo J
Oncotarget; 2016 Mar; 7(13):16479-89. PubMed ID: 26918725
[TBL] [Abstract][Full Text] [Related]
3. Treatment of colon cancer with oncolytic herpes simplex virus in preclinical models.
Yang H; Peng T; Li J; Wang Y; Zhang W; Zhang P; Peng S; Du T; Li Y; Yan Q; Liu B
Gene Ther; 2016 May; 23(5):450-9. PubMed ID: 26871935
[TBL] [Abstract][Full Text] [Related]
4. RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancer.
Homicsko K; Lukashev A; Iggo RD
Cancer Res; 2005 Aug; 65(15):6882-90. PubMed ID: 16061672
[TBL] [Abstract][Full Text] [Related]
5. Eliminating established tumor in nu/nu nude mice by a tumor necrosis factor-alpha-related apoptosis-inducing ligand-armed oncolytic adenovirus.
Dong F; Wang L; Davis JJ; Hu W; Zhang L; Guo W; Teraishi F; Ji L; Fang B
Clin Cancer Res; 2006 Sep; 12(17):5224-30. PubMed ID: 16951242
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy with CTL cells and oncolytic adenovirus expressing IL-15-induced enhanced antitumor activity.
Yan Y; Li S; Jia T; Du X; Xu Y; Zhao Y; Li L; Liang K; Liang W; Sun H; Li R
Tumour Biol; 2015 Jun; 36(6):4535-43. PubMed ID: 25627006
[TBL] [Abstract][Full Text] [Related]
7. A chimeric poxvirus with J2R (thymidine kinase) deletion shows safety and anti-tumor activity in lung cancer models.
Chaurasiya S; Chen NG; Lu J; Martin N; Shen Y; Kim SI; Warner SG; Woo Y; Fong Y
Cancer Gene Ther; 2020 Apr; 27(3-4):125-135. PubMed ID: 31209267
[TBL] [Abstract][Full Text] [Related]
8. Molecular network pathways and functional analysis of tumor signatures associated with development of resistance to viral gene therapy.
Song TJ; Haddad D; Adusumilli P; Kim T; Stiles B; Hezel M; Socci ND; Gönen M; Fong Y
Cancer Gene Ther; 2012 Jan; 19(1):38-48. PubMed ID: 22015641
[TBL] [Abstract][Full Text] [Related]
9. Macrophage metalloelastase (MME) as adjuvant for intra-tumoral injection of oncolytic adenovirus and its influence on metastases development.
Lavilla-Alonso S; Bauer MM; Abo-Ramadan U; Ristimäki A; Halavaara J; Desmond RA; Wang D; Escutenaire S; Ahtiainen L; Saksela K; Tatlisumak T; Hemminki A; Pesonen S
Cancer Gene Ther; 2012 Feb; 19(2):126-34. PubMed ID: 22095385
[TBL] [Abstract][Full Text] [Related]
10. Development of the oncolytic virus, CF33, and its derivatives for peritoneal-directed treatment of gastric cancer peritoneal metastases.
Yang A; Zhang Z; Chaurasiya S; Park AK; Jung A; Lu J; Kim SI; Priceman S; Fong Y; Woo Y
J Immunother Cancer; 2023 Apr; 11(4):. PubMed ID: 37019471
[TBL] [Abstract][Full Text] [Related]
11. Improved replication efficiency of echovirus 5 after transfection of colon cancer cells using an authentic 5' RNA genome end methodology.
Israelsson S; Sävneby A; Ekström JO; Jonsson N; Edman K; Lindberg AM
Invest New Drugs; 2014 Dec; 32(6):1063-70. PubMed ID: 25052234
[TBL] [Abstract][Full Text] [Related]
12. Expressing human interleukin-15 from oncolytic vesicular stomatitis virus improves survival in a murine metastatic colon adenocarcinoma model through the enhancement of anti-tumor immunity.
Stephenson KB; Barra NG; Davies E; Ashkar AA; Lichty BD
Cancer Gene Ther; 2012 Apr; 19(4):238-46. PubMed ID: 22158521
[TBL] [Abstract][Full Text] [Related]
13. Recombinant Orthopoxvirus Primes Colon Cancer for Checkpoint Inhibitor and Cross-Primes T Cells for Antitumor and Antiviral Immunity.
Kim SI; Park AK; Chaurasiya S; Kang S; Lu J; Yang A; Sivanandam V; Zhang Z; Woo Y; Priceman SJ; Fong Y; Warner SG
Mol Cancer Ther; 2021 Jan; 20(1):173-182. PubMed ID: 33262221
[TBL] [Abstract][Full Text] [Related]
14. Augmenting the antitumor effect of TRAIL by SOCS3 with double-regulated replicating oncolytic adenovirus in hepatocellular carcinoma.
Wei RC; Cao X; Gui JH; Zhou XM; Zhong D; Yan QL; Huang WD; Qian QJ; Zhao FL; Liu XY
Hum Gene Ther; 2011 Sep; 22(9):1109-19. PubMed ID: 21361790
[TBL] [Abstract][Full Text] [Related]
15. Directed evolution generates a novel oncolytic virus for the treatment of colon cancer.
Kuhn I; Harden P; Bauzon M; Chartier C; Nye J; Thorne S; Reid T; Ni S; Lieber A; Fisher K; Seymour L; Rubanyi GM; Harkins RN; Hermiston TW
PLoS One; 2008 Jun; 3(6):e2409. PubMed ID: 18560559
[TBL] [Abstract][Full Text] [Related]
16. Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cells.
Fuerer C; Homicsko K; Lukashev AN; Pittet AL; Iggo RD
BMC Cancer; 2006 Oct; 6():236. PubMed ID: 17020613
[TBL] [Abstract][Full Text] [Related]
17. Novel oncolytic chimeric orthopoxvirus causes regression of pancreatic cancer xenografts and exhibits abscopal effect at a single low dose.
O'Leary MP; Choi AH; Kim SI; Chaurasiya S; Lu J; Park AK; Woo Y; Warner SG; Fong Y; Chen NG
J Transl Med; 2018 Apr; 16(1):110. PubMed ID: 29699566
[TBL] [Abstract][Full Text] [Related]
18. Defining Effective Combinations of Immune Checkpoint Blockade and Oncolytic Virotherapy.
Rojas JJ; Sampath P; Hou W; Thorne SH
Clin Cancer Res; 2015 Dec; 21(24):5543-51. PubMed ID: 26187615
[TBL] [Abstract][Full Text] [Related]
19.
Jung MY; Offord CP; Ennis MK; Kemler I; Neuhauser C; Dingli D
Cancer Res; 2018 Oct; 78(20):5992-6000. PubMed ID: 30115692
[TBL] [Abstract][Full Text] [Related]
20. Etoposide enhances antitumor efficacy of MDR1-driven oncolytic adenovirus through autoupregulation of the MDR1 promoter activity.
Su BH; Shieh GS; Tseng YL; Shiau AL; Wu CL
Oncotarget; 2015 Nov; 6(35):38308-26. PubMed ID: 26515462
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]